News

Acarix is a Swedish MedTech company marketing the CADScor®System – the innovative, non-invasive and ultra-sensitive analytical device designed to support a reliable and cost-effective rule-out of significant coronary artery disease (CAD) at the very first stage of the diagnostic pathway.

We are committed to bringing about a change in the early warning and assessment of cardiac and vascular diseases. Our latest news can be found below.